IBDEI223 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32818,2)
 ;;=^5005879
 ;;^UTILITY(U,$J,358.3,32819,0)
 ;;=H40.43X2^^128^1670^29
 ;;^UTILITY(U,$J,358.3,32819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32819,1,3,0)
 ;;=3^Inflam GLC,OU,Moderate Stage
 ;;^UTILITY(U,$J,358.3,32819,1,4,0)
 ;;=4^H40.43X2
 ;;^UTILITY(U,$J,358.3,32819,2)
 ;;=^5005880
 ;;^UTILITY(U,$J,358.3,32820,0)
 ;;=H40.43X3^^128^1670^30
 ;;^UTILITY(U,$J,358.3,32820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32820,1,3,0)
 ;;=3^Inflam GLC,OU,Severe Stage
 ;;^UTILITY(U,$J,358.3,32820,1,4,0)
 ;;=4^H40.43X3
 ;;^UTILITY(U,$J,358.3,32820,2)
 ;;=^5005881
 ;;^UTILITY(U,$J,358.3,32821,0)
 ;;=H40.43X4^^128^1670^31
 ;;^UTILITY(U,$J,358.3,32821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32821,1,3,0)
 ;;=3^Inflam GLC,OU,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,32821,1,4,0)
 ;;=4^H40.43X4
 ;;^UTILITY(U,$J,358.3,32821,2)
 ;;=^5005882
 ;;^UTILITY(U,$J,358.3,32822,0)
 ;;=H40.42X0^^128^1670^22
 ;;^UTILITY(U,$J,358.3,32822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32822,1,3,0)
 ;;=3^Inflam GLC,OS,Stage Unspec
 ;;^UTILITY(U,$J,358.3,32822,1,4,0)
 ;;=4^H40.42X0
 ;;^UTILITY(U,$J,358.3,32822,2)
 ;;=^5005874
 ;;^UTILITY(U,$J,358.3,32823,0)
 ;;=H40.42X1^^128^1670^23
 ;;^UTILITY(U,$J,358.3,32823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32823,1,3,0)
 ;;=3^Inflam GLC,OS,Mild Stage
 ;;^UTILITY(U,$J,358.3,32823,1,4,0)
 ;;=4^H40.42X1
 ;;^UTILITY(U,$J,358.3,32823,2)
 ;;=^5005875
 ;;^UTILITY(U,$J,358.3,32824,0)
 ;;=H40.42X2^^128^1670^24
 ;;^UTILITY(U,$J,358.3,32824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32824,1,3,0)
 ;;=3^Inflam GLC,OS,Moderate Stage
 ;;^UTILITY(U,$J,358.3,32824,1,4,0)
 ;;=4^H40.42X2
 ;;^UTILITY(U,$J,358.3,32824,2)
 ;;=^5005876
 ;;^UTILITY(U,$J,358.3,32825,0)
 ;;=H40.42X3^^128^1670^25
 ;;^UTILITY(U,$J,358.3,32825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32825,1,3,0)
 ;;=3^Inflam GLC,OS,Severe Stage
 ;;^UTILITY(U,$J,358.3,32825,1,4,0)
 ;;=4^H40.42X3
 ;;^UTILITY(U,$J,358.3,32825,2)
 ;;=^5133506
 ;;^UTILITY(U,$J,358.3,32826,0)
 ;;=H40.42X4^^128^1670^26
 ;;^UTILITY(U,$J,358.3,32826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32826,1,3,0)
 ;;=3^Inflam GLC,OS,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,32826,1,4,0)
 ;;=4^H40.42X4
 ;;^UTILITY(U,$J,358.3,32826,2)
 ;;=^5005877
 ;;^UTILITY(U,$J,358.3,32827,0)
 ;;=H40.41X0^^128^1670^17
 ;;^UTILITY(U,$J,358.3,32827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32827,1,3,0)
 ;;=3^Inflam GLC,OD,Stage Unspec
 ;;^UTILITY(U,$J,358.3,32827,1,4,0)
 ;;=4^H40.41X0
 ;;^UTILITY(U,$J,358.3,32827,2)
 ;;=^5005870
 ;;^UTILITY(U,$J,358.3,32828,0)
 ;;=H40.41X1^^128^1670^18
 ;;^UTILITY(U,$J,358.3,32828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32828,1,3,0)
 ;;=3^Inflam GLC,OD,Mild Stage
 ;;^UTILITY(U,$J,358.3,32828,1,4,0)
 ;;=4^H40.41X1
 ;;^UTILITY(U,$J,358.3,32828,2)
 ;;=^5005871
 ;;^UTILITY(U,$J,358.3,32829,0)
 ;;=H40.41X2^^128^1670^19
 ;;^UTILITY(U,$J,358.3,32829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32829,1,3,0)
 ;;=3^Inflam GLC,OD,Moderate Stage
 ;;^UTILITY(U,$J,358.3,32829,1,4,0)
 ;;=4^H40.41X2
 ;;^UTILITY(U,$J,358.3,32829,2)
 ;;=^5005872
 ;;^UTILITY(U,$J,358.3,32830,0)
 ;;=H40.41X3^^128^1670^20
 ;;^UTILITY(U,$J,358.3,32830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32830,1,3,0)
 ;;=3^Inflam GLC,OD,Severe Stage
 ;;^UTILITY(U,$J,358.3,32830,1,4,0)
 ;;=4^H40.41X3
 ;;^UTILITY(U,$J,358.3,32830,2)
 ;;=^5133505
 ;;^UTILITY(U,$J,358.3,32831,0)
 ;;=H40.41X4^^128^1670^21
